Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

US Patent 11492411 · Granted Nov 8, 2022

Estimated economic value: $976,777,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding molecules with modified J-chain2025
Antibody constructs for CDH19 and CD32025
Bivalent bispecific antibody and preparation method thereof, coding gene, host c2025
Method and apparatus for deposition of piezo-electric materials2025
Engineered γδ T-cells2025
Methods for selective expansion of gamma delta t-cell populations and compositio2025
Anti-CD47 monoclonal antibody and use thereof2025
Liver-specific viral promoters and methods of using the same2025
MAGEB2 binding constructs2025
Humanized anti-A β monoclonal antibody and application thereof2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025
Methods for selective expansion of delta-3 gamma delta T-cell populations and co2025